Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Inflammatory bowel disease and colorectal cancer

Inflammatory Bowel Disease (IBD) is the name given to describe two main conditions; Crohn’s disease and Ulcerative Colitis.  Both of these are long-term conditions which involve inflammation of the digestive system.There is some evidence that patients with IBD are at an increased risk of ... [read more]

 

The risk of colorectal cancer in individuals with cystic fibrosis: an English population-based study

Cystic fibrosis (CF) is an inherited genetic disease that damages the lungs, digestive system and other systems of the body.  The damage is caused by a fault in a gene that affects the movement of salt and water in and out of cells which can lead to a build-up of thick, sticky mucous.  This mucous ... [read more]

 

Variation in post-colonoscopy colorectal cancer across colonoscopy providers in the English National Health Service: A population-based cohort study – Update

Colonoscopy is the main diagnostic test used to identify colorectal (or bowel) cancer and involves a thin tube with a camera on the end of it being inserted into the bowel to look for a tumour.  Colonoscopy is used a lot by the National Health Service (NHS) with over 650,000 ... [read more]

 

Treatment of liver metastases in colorectal cancer

Bowel cancer that spreads to the liver (known as liver metastases) can sometimes be treated and cured. This project is looking at how surgery and ablation (freezing or burning) are used in such treatment across England.  If differences exist, we will look to see if the patients ...  [read more]

 

Treatment of pulmonary metastases in colorectal cancer

Plain Language Summary: This study is to see if there are any differences between hospitals in the way surgery is used to treat colorectal cancer that has spread to the lungs. It will also look at outcome to try and identify best practice. [Read more]

 

A comparison of colorectal cancer management and outcome in Denmark and Yorkshire

The number of patients surviving after a bowel cancer diagnosis has improved over recent decades in many European countries. Despite historically having similar survival rates to the UK, Denmark has recently seen greater improvement than the UK. This improvement follows special measures ... [read more]

 

Quality Measures for Colorectal Cancer

The UK Colorectal Cancer Intelligence Hub has developed a set of measures to assess the type and quality of care a patient receives during their diagnosis and treatment for colorectal cancer. The measures can be updated on a yearly basis and applied to all colorectal cancer Multi-Disciplinary Teams ... [read more]

 

Diabetes complications and their relationship with outcomes from colorectal cancer

Up to 20% of cancer patients also have diabetes.  Having diabetes is known to be linked with worse outcomes for patients after cancer surgery. Patients who have other health conditions related to their diabetes (complications) have a lower life expectancy and also have more frequent visits to the health ... [read more]